secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001731122-23-001319
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Enochian BioSciences shareholders elect 7 directors, approve 2023 equity plan, ratify auditor
--------------------------------------------------------------------------------

- All seven director nominees elected: René Sindlev, Mark Dybul, Carol Brosgart, Gregg Alton, James Sapirstein, Henrik Gronfeldt-Sorensen, Jayne McNicol.
- 2023 Equity Incentive Plan approved with 18,785,519 votes for, 34,914 against, 1,528,369 broker non-votes.
- Ratification of Sadler, Gibb & Associates as independent auditor passed: 20,327,508 for, 16,107 against, 13,456 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001319/0001731122-23-001319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112223001319/e4878_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-23-001319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer